87
Participants
Start Date
July 31, 2008
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
MEDI-545
100 mg once; SC Placebo × 12 doses on other weeks
MEDI-545
100 mg every 4 weeks × 4 doses; SC Placebo × 9 doses on other weeks
MEDI-545
100 mg every 2 weeks × 7 doses; SC Placebo × 6 doses on other weeks
MEDI-545
100 mg every week × 13 doses
Placebo
SC Placebo every week × 13 doses
Research Site, Brooklyn
Research Site, Baltimore
Research Site, Charlotte
Research Site, Columbia
Research Site, Charleston
Research Site, Decatur
Research Site, Marrietta
Research Site, West Fayetteville
Research Site, Atlanta
Research Site, Ocala
Research Site, Anniston
Research Site, Cincinnati
Research Site, Lansing
Research Site, Oklahoma City
Research Site, Houston
Research Site, Sugarland
Research Site, Colorado Springs
Research Site, Upland
Research Site, Huntington Beach
Research Site, Seattle
Research Site, Farmington
Research Site, Clearwater
Lead Sponsor
MedImmune LLC
INDUSTRY